loading
Schlusskurs vom Vortag:
$2.71
Offen:
$2.69
24-Stunden-Volumen:
237.86K
Relative Volume:
0.64
Marktkapitalisierung:
$55.78M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-94.11M
KGV:
-0.4443
EPS:
-6.01
Netto-Cashflow:
$-86.06M
1W Leistung:
+1.52%
1M Leistung:
+18.67%
6M Leistung:
-40.27%
1J Leistung:
-65.59%
1-Tages-Spanne:
Value
$2.64
$2.805
1-Wochen-Bereich:
Value
$2.58
$2.9949
52-Wochen-Spanne:
Value
$1.78
$8.58

Adverum Biotechnologies Inc Stock (ADVM) Company Profile

Name
Firmenname
Adverum Biotechnologies Inc
Name
Telefon
(650) 649-1004
Name
Adresse
100 CARDINAL WAY, REDWOOD CITY, CA
Name
Mitarbeiter
155
Name
Twitter
@adverumbio
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
ADVM's Discussions on Twitter

Vergleichen Sie ADVM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ADVM
Adverum Biotechnologies Inc
2.67 54.94M 0 -94.11M -86.06M -6.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-06-25 Eingeleitet Oppenheimer Outperform
2024-04-30 Eingeleitet H.C. Wainwright Buy
2022-07-07 Hochstufung Truist Hold → Buy
2021-07-23 Herabstufung Cantor Fitzgerald Overweight → Neutral
2021-05-03 Herabstufung SVB Leerink Outperform → Mkt Perform
2021-04-29 Herabstufung Chardan Capital Markets Buy → Neutral
2021-04-29 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2021-04-29 Herabstufung Truist Buy → Hold
2020-12-16 Eingeleitet UBS Neutral
2020-11-12 Hochstufung Raymond James Underperform → Mkt Perform
2020-06-26 Herabstufung Raymond James Mkt Perform → Underperform
2020-05-13 Eingeleitet RBC Capital Mkts Outperform
2020-05-05 Hochstufung SunTrust Hold → Buy
2020-04-28 Eingeleitet Goldman Buy
2020-03-16 Eingeleitet SVB Leerink Outperform
2020-02-10 Hochstufung Cantor Fitzgerald Neutral → Overweight
2020-02-10 Hochstufung Chardan Capital Markets Neutral → Buy
2019-10-15 Bestätigt Chardan Capital Markets Neutral
2019-09-13 Bestätigt Chardan Capital Markets Neutral
2019-06-14 Fortgesetzt Raymond James Mkt Perform
2018-11-02 Herabstufung Raymond James Outperform → Mkt Perform
2018-11-02 Herabstufung SunTrust Buy → Hold
2018-09-21 Eingeleitet Cantor Fitzgerald Overweight
2018-08-30 Eingeleitet SunTrust Buy
2018-02-15 Fortgesetzt Piper Jaffray Overweight
2017-10-12 Eingeleitet Raymond James Outperform
Alle ansehen

Adverum Biotechnologies Inc Aktie (ADVM) Neueste Nachrichten

pulisher
01:58 AM

Is Adverum Biotechnologies Inc. a good long term investmentFree Daily Trading Room Entry - Autocar Professional

01:58 AM
pulisher
Jul 22, 2025

What analysts say about Adverum Biotechnologies Inc. stockHigh-octane gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Adverum Biotechnologies Inc. Stock Analysis and ForecastMarket-leading capital gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Adverum Biotechnologies Inc. stock priceOutstanding stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream - GlobeNewswire Inc.

Jul 16, 2025
pulisher
Jul 16, 2025

How Adverum Biotechnologies Inc. stock performs during market volatilityFree Access to Investment Community - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

what makes adverum biotechnologies inc. stock price move sharplyDaily Volume Leaders - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Adverum Biotechnologies Inc. stock price move sharplyFree Access to Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Adverum Biotechnologies Inc. stock attracts strong analyst attentionProven High Yield Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Adverum Biotechnologies Up 22%, Insiders Still Down After US$526.8k Purchase - simplywall.st

Jul 15, 2025
pulisher
Jul 15, 2025

Reversal Of Fortune For Adverum Biotechnologies Insiders Who Made A US$526.8k Purchase - Yahoo Finance

Jul 15, 2025
pulisher
Jun 30, 2025

Adverum Biotechnologies, Inc.(NasdaqCM: ADVM) dropped from Russell 3000 Index - MarketScreener

Jun 30, 2025
pulisher
Jun 18, 2025

Adverum Biotechnologies shareholders approve stock option repricing - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Adverum Biotechnologies shareholders approve stock option repricing By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 13, 2025

Adverum Biotechnologies’ SWOT analysis: gene therapy stock faces pivotal year - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 06, 2025

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jun 06, 2025
pulisher
Jun 06, 2025

Adverum Biotechnologies (NASDAQ:ADVM) versus Metagenomi (NASDAQ:MGX) Head-To-Head Analysis - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Adverum Awards 14,610 Shares in Stock Options and RSUs to Key New Hires - Stock Titan

Jun 05, 2025
pulisher
May 16, 2025

Adverum Biotechnologies Reports Q1 2025 Financial Results - TipRanks

May 16, 2025
pulisher
May 15, 2025

Adverum Biotechnologies (ADVM) Sees Price Target Adjustment by RBC Capital | ADVM Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adverum Biotechnologies (ADVM) Receives Continued Buy Rating from Chardan Capital | ADVM Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adverum Biotechnologies (ADVM) Price Target Reduced by RBC Capit - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Adverum Biotechnologies (ADVM) Rating Reiterated at 'Buy' by HC Wainwright | ADVM Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

RBC Cuts Price Target on Adverum Biotechnologies to $4 From $5, Keeps Sector Perform, Speculative Risk - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Adverum Biotechnologies: Q1 Earnings Snapshot - CT Insider

May 15, 2025
pulisher
May 14, 2025

Adverum (ADVM) Projects Funding Through Late 2025 | ADVM Stock N - GuruFocus

May 14, 2025

Finanzdaten der Adverum Biotechnologies Inc-Aktie (ADVM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):